Valion Bio VBIO Ratios (2021-2026)

NASDAQ VBIO
$0.12 +0.00 (+0.41%)
At close: Aug 21, 2026 · 4:00 PM EDT
Ratios Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Profitability
Gross Margin (Quarter)
-12.31%-9.39%-0.51%16.36%23.67%13.21%10.54%30.05%37.89%38.30%1.40%50.00%21.43%34.92%-132.78%71.43%62.79%-99.32%91.25%-115.38%
EBT Margin (Quarter)
-476.87%-443.68%-589.20%-598.36%-581.06%-552.20%-565.44%-576.06%-1,352.17%-642.20%-643.14%-458.68%-947.14%-1,135.71%-838.89%-2,151.43%-2,248.84%-1,697.95%91.25%-40,038.46%
EBIT Margin (Quarter)
-393.66%-443.68%-589.20%-523.60%-571.59%-541.72%-552.94%-562.77%-1,319.88%-624.11%-628.57%-443.41%-904.29%-1,135.71%-823.89%-2,151.43%-2,248.84%-1,700.68%91.25%-115.38%
EBITDA Margin (Quarter)
-393.66%-443.68%-589.20%-523.60%-571.59%-541.72%-552.94%-562.77%-1,319.88%-624.11%-628.57%-443.41%-904.29%-1,135.71%-823.89%-2,151.43%-2,248.84%-1,700.68%91.25%-115.38%
Operating Margin (Quarter)
-393.66%-443.68%-589.20%-523.60%-571.59%-541.72%-552.94%-562.77%-1,319.88%-624.11%-628.57%-443.41%-904.29%-1,135.71%-823.89%-2,151.43%-2,248.84%-1,700.68%91.25%-115.38%
Net Margin (Quarter)
-476.87%-443.68%-589.20%-523.36%-581.06%-552.20%-565.44%-576.06%-1,352.17%-642.20%-643.14%-458.68%-947.14%-1,135.71%-838.89%-2,151.43%-2,248.84%-1,697.95%91.25%-40,038.46%
FCF Margin (Quarter)
-202.61%-593.50%-709.51%-515.42%-321.97%-588.05%-543.87%-670.21%-1,551.55%-638.30%-507.28%-508.98%-895.00%-1,148.41%-378.89%-1,285.71%-2,093.02%-1,376.71%-2,906.25%
Efficiency
Inventory Average (Quarter)
0.44M0.64M0.80M0.81M0.90M0.97M0.96M0.84M0.78M0.78M0.75M0.53M0.31M0.46M0.60M0.38M0.47M
Assets Average (Quarter)
13.87M11.86M9.62M7.04M6.49M5.85M5.80M6.08M4.22M4.03M4.09M3.10M3.29M4.14M5.37M18.92M32.04M
Invested Capital (Quarter)
16.25M16.25M
Asset Utilization Ratio (Quarter)
0.100.140.190.260.280.240.210.190.270.280.230.250.160.110.090.020.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-4.73-7.00-60.36-51.68-44.24-42.32-40.87-34.51-43.15-29.04-21.10-54.930.430.00
Debt Ratio (Quarter)
0.08
Times Interest Earned (Quarter)
-4.73-7.00-60.36-51.68-44.24-42.32-40.87-34.51-43.15-29.04-21.10-54.930.430.00
Valuation
Enterprise Value (Quarter)
-12.79M-10.34M-9.00M-6.33M-3.52M-5.00M-2.17M-4.74M-3.24M-1.24M-3.24M-2.10M-2.00M-0.67M-1.18M-3.45M-12.60M-2.20M
Return Ratios
Return on Sales (Quarter)
-0.05%-0.04%-0.06%-0.06%-0.06%-0.06%-0.06%-0.06%-0.14%-0.06%-0.06%-0.05%-0.09%-0.11%-0.08%-0.22%-0.22%-0.17%0.01%-4.00%
Return on Capital Employed (Quarter)
-53.39%-92.60%-133.46%-195.58%-202.93%-193.69%-171.97%-176.14%-235.64%-196.05%-182.00%-200.14%-222.89%-191.30%-156.56%-32.02%-15.14%
Return on Assets (Quarter)
-0.01%-0.01%-0.01%-0.02%-0.02%-0.02%-0.01%-0.01%-0.02%-0.02%-0.02%-0.02%-0.02%-0.02%-0.01%0.00%-0.01%